Rhythm Biosciences Ltd logo

Rhythm Biosciences Ltd

ASX:RHY (Australia)  
A$ 0.34 (-8.82%) Sep 26
P/E:
At Loss
P/B:
11.48
Market Cap:
A$ 75.19M ($ 47.88M)
Enterprise V:
A$ 71.10M ($ 45.27M)
Volume:
137.90K
Avg Vol (2M):
171.85K
Also Trade In:
Volume:
137.90K
Market Cap A$:
75.19M
Market Cap $:
47.88M
PE Ratio:
At Loss
Avg Vol (2M):
171.85K
Enterprise Value A$:
71.10M
Enterprise Value $:
45.27M
PB Ratio:
11.48

Business Description

Description
Rhythm Biosciences Ltd is a medical diagnostics technology company. It is engaged in developing and commercializing Australian medical diagnostics technology for sale to national and international markets. Its product includes ColoSTAT a proposed diagnostic blood test for screening for colorectal cancer. Geographically, the company operates only in Australia.
Name Current Vs Industry Vs History
Cash-To-Debt 49.05
Equity-to-Asset 0.76
Debt-to-Equity 0.01
Debt-to-EBITDA -0.01
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 34.51
9-Day RSI 37.15
14-Day RSI 38.36
6-1 Month Momentum % -24.24
12-1 Month Momentum % -68.62

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.03
Quick Ratio 2.46
Cash Ratio 2.36

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -23.9
Shareholder Yield % -2.97
Name Current Vs Industry Vs History
ROE % -111.85
ROA % -94.18
ROIC % -895.19
ROC (Joel Greenblatt) % -1849.68
ROCE % -155

Financials

ASX:RHY's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Rhythm Biosciences Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$)
EPS (TTM) (A$) -0.038
Beta 2.77
Volatility % 52.58
14-Day RSI 38.36
14-Day ATR (A$) 0.028008
20-Day SMA (A$) 0.34675
12-1 Month Momentum % -68.62
52-Week Range (A$) 0.3 - 1.31
Shares Outstanding (Mil) 221.14

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Rhythm Biosciences Ltd Filings

Filing Date Document Date Form
No Filing Data

Rhythm Biosciences Ltd Stock Events

Event Date Price(A$)
No Event Data

Rhythm Biosciences Ltd Frequently Asked Questions

What is Rhythm Biosciences Ltd(ASX:RHY)'s stock price today?
The current price of ASX:RHY is A$0.34. The 52 week high of ASX:RHY is A$1.31 and 52 week low is A$0.30.
When is next earnings date of Rhythm Biosciences Ltd(ASX:RHY)?
The next earnings date of Rhythm Biosciences Ltd(ASX:RHY) is .
Does Rhythm Biosciences Ltd(ASX:RHY) pay dividends? If so, how much?
Rhythm Biosciences Ltd(ASX:RHY) does not pay dividend.

Press Release

Subject Date
No Press Release